Join the Lupus Nephritis group to help and get support from people like you.
Lupus Nephritis News
Obinutuzumab Preserves Kidney Function in Lupus Nephritis
THURSDAY, Nov. 16, 2023 – For patients with lupus nephritis (LN), obinutuzumab treatment results in better preservation of kidney function and prevention of LN flares, according to a study published...
Voclosporin Safe, Effective for Long-Term Treatment of Lupus Nephritis
WEDNESDAY, July 26, 2023 – Voclosporin can preserve kidney function up to three years for patients with lupus nephritis, according to a study published online July 19 in Arthritis & Rheumatology....
GSK Announces US FDA Approval of Benlysta (belimumab) for Pediatric Patients with Active Lupus Nephritis
Benlysta is now the first and only biologic approved for adults and children who have lupus or lupus nephritis London UK 27 July 2022 – GSK plc (LSE/NYSE: GSK) today announced that the US Food and...
FDA Approves Lupkynis (voclosporin) for Adult Patients with Active Lupus Nephritis
VICTORIA, British Columbia & ROCKVILLE, Md.-- January 22, 2021 – Aurinia Pharmaceuticals Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved Lupkynis (voclosporin) in...
FDA Approves GSK’s Benlysta as the First Medicine for Adult Patients with Active Lupus Nephritis in the US
17 December 2020 -- GlaxoSmithKline plc (LSE/NYSE: GSK) announced the US Food and Drug Administration (FDA) has approved Benlysta (belimumab) for the treatment of adult patients with active lupus ...
Ask a question
To post your own question to this support group, sign in or create an account.